Previous 10 | Next 10 |
2023-09-15 16:44:31 ET More on Aditx Therapeutics Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earnings data for Aditx Therapeutics Financial information for Aditx Therapeutics Aditxt stock drops 48% on $10M private placement A...
Aditxt (NASDAQ: ADTX) , a global innovation company focused on developing and commercializing technologies that monitor and modulate the immune system, will be participating in the 25th annual H.C. Wainwright Global Investment Conference; the premier event is scheduled for Sept. 11–13...
Aditxt Chairman, Co-Founder, and Chief Executive Officer Amro Albanna will deliver the company presentation on September 13 th at 4:30 p.m. EST. Aditxt, ® Inc , (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused o...
Aditxt (NASDAQ: ADTX) , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has closed on its previously announced private placement. The placement was comprised of the purchase and sale of one million shares of commo...
Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has closed its previously announced private placement for the purchase and sale of an ag...
2023-09-05 08:36:44 ET TradeUP Acquisition ( UPTD ) -30% . Aditxt ( ADTX ) -23% . Edible Garden AG Incorporated ( EDBL ) -18% . Reliance Global Group ( RELI ) -14% . TRxADE HEALTH ( MEDS ) -12% . Tonix Pharmaceuticals Holding ( ...
2023-09-05 06:14:15 ET Aditxt ( NASDAQ: ADTX ) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year. This sell-off continued on Tuesday, with the shares collapsing by over 14% in the pre-market ses...
2023-09-01 08:42:36 ET Aditxt ( ADTX ) -49% announces $10.0 Million private placement priced at-the-market under Nasdaq rules. iCoreConnect ( ICCT ) -22% . Flora Growth Corp. ( FLGC ) -17% . Biodexa Pharmaceuticals ( BDRX ) -15% . Tingo ...
2023-09-01 02:14:15 ET Aditxt ( NASDAQ: ADTX ) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the market under Nasdaq rules. Each share of common stock is being offered...
Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
Aditxt (NASDAQ: ADTX) , a company dedicated to discovering, developing and deploying promising health innovations, and Evofem Biosciences Inc. (OTCQB: EVFM) are announcing a new market partnership with Hello Alpha, a telemedicine company with a medical team specifically trained f...
Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare PR Newswire — Leading telemedicine company expands offering with hormone-free birth control as GLP-1 medication usage increases ...
Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...